Advantages of nanorobot-based drug delivery:

a) Targeted delivery: Nanorobots can be designed to target specific cells, tissues, or organs, minimizing off-target effects and reducing systemic toxicity⁸.

b) Enhanced specificity: By leveraging surface modifications and targeting ligands, nanorobots can recognize and bind to specific biomarkers associated with diseases, leading to improved precision in drug delivery⁹.

c) Site-specific release: Nanorobots can release drugs or therapeutic agents directly at the target site, allowing for localized treatment and reducing the required drug dosage¹⁰.

d) Overcoming biological barriers: Some nanorobot-based systems can bypass biological barriers, such as the blood-brain barrier, enabling the delivery of drugs to previously inaccessible regions¹¹.

Limitations of nanorobot-based drug delivery:

a) Biocompatibility and safety: Ensuring the biocompatibility of nanorobots is crucial to prevent adverse reactions and immune responses within the body¹².

b) Nanorobot stability: Nanorobots must maintain their structural integrity and functionality in various physiological environments for successful drug delivery¹³.

b) Large-Scale production: Mass production of nanorobots with consistent quality and reproducibility remains a challenge¹⁴.

c) Regulatory approval: The regulatory landscape for nanorobot-based drug delivery systems is still evolving, requiring rigorous testing and validation for clinical translation¹⁵.

d) Targeted drug delivery and enhanced specificity: One of the most significant advantages of nanorobot-based drug delivery is the ability to achieve targeted and site-specific treatments. Through surface modifications and the incorporation of specific targeting moieties, nanorobots can identify diseased cells or tissues with high specificity. This capability enables the delivery of therapeutic agents directly to the affected areas, reducing the risk of side effects on healthy tissues and organs. Additionally, targeted drug delivery enhances the therapeutic efficacy of medications, as higher concentrations of drugs reach the intended sites, improving treatment outcomes^5,6,9.

NANOROBOTICS IN DRUG DEVELOPMENT:

a) Accelerating drug discovery with nanorobotics:

Nanorobotics plays a crucial role in accelerating the drug discovery process, which traditionally involves time-consuming and costly experimentation. Nanorobots can significantly enhance the efficiency of drug screening and identification of potential therapeutic candidates. By leveraging their precise manipulation capabilities, nanorobots can rapidly test a vast number of compounds in parallel, expediting the identification of molecules with desirable pharmacological properties. This accelerated drug discovery process holds the promise of reducing the time and resources required to bring new drugs to market, ultimately benefiting patients in need of innovative treatments¹⁶.

b) High-throughput screening using nanorobots:

High-throughput screening (HTS) is a critical step in drug development, where large libraries of compounds are screened to identify those with potential therapeutic effects. Nanorobots enable miniaturized and automated HTS platforms, allowing for the rapid testing of thousands to millions of drug candidates simultaneously. These nanoscale screening systems can efficiently analyze various parameters, such as binding affinity, drug-receptor interactions, and cellular responses, providing valuable data to identify lead compounds for further investigation. Through HTS using nanorobots, researchers can uncover novel drug candidates more efficiently and with higher precision¹⁷.

c) Rational drug design and optimization:

Nanorobotics facilitates rational drug design, a strategy that involves the targeted design of new pharmaceutical agents based on an understanding of the target's structure and function. Molecular simulations and computational models are combined with nanorobots' ability to manipulate and analyze individual molecules. This integration empowers researchers to predict the interactions between drugs and biological targets more accurately. By using nanorobotic techniques to fine-tune drug molecules, researchers can optimize drug candidates for improved efficacy, safety, and specificity. This rational drug design approach holds the potential to revolutionize the process of drug development, resulting in tailor-made medications for specific diseases and patient populations¹⁸.

d) Nanorobotics in personalized medicine:

Personalized medicine aims to customize medical treatments to individual patients based on their unique genetic makeup, lifestyle, and disease characteristics. Nanorobotics plays a pivotal role in advancing personalized medicine by enabling targeted and precise therapies. Nanorobots can be programmed to detect specific biomarkers indicative of a patient's condition, enabling early diagnosis and treatment. Moreover, nanorobot-based drug delivery systems can deliver therapeutic agents with precise dosages and timing tailored to the patient's needs. The integration of nanorobotics with personalized medicine holds the potential to revolutionize disease management, enhancing treatment outcomes and minimizing adverse effects¹⁹.

Types of Nanorobots for Pharmaceutical Applications

a) Molecular nanorobots:

Molecular nanorobots are tiny machines constructed at the molecular level, typically using DNA-based nanotechnology, nanoscale materials, or organic compounds. These nanorobots have the ability to perform precise tasks at the nanoscale and are well-suited for various pharmaceutical applications. In drug delivery, molecular nanorobots can be engineered to carry therapeutic payloads, such as drugs or genetic material, and navigate through the bloodstream to target specific sites. Their small size allows them to penetrate cellular barriers and deliver payloads directly into cells or organelles, enabling highly targeted treatments. Additionally, molecular nanorobots can be designed to perform diagnostic functions, detecting specific biomarkers associated with diseases, thus enabling early disease diagnosis and monitoring²⁰.

b) Cellular nanorobots:

Cellular nanorobots are nanoscale machines constructed using living cells or cell-like structures. These nanorobots harness the unique functionalities of biological cells to perform specific tasks in pharmaceutical applications. Cellular nanorobots can be engineered to target and deliver therapeutic agents to specific tissues or organs. By modifying the surface receptors or using cell membrane cloaking techniques, these nanorobots can evade the immune system and effectively deliver drugs to their intended targets. Cellular nanorobots have shown promising results in cancer therapy, where they can be programmed to seek out and destroy cancer cells selectively, while leaving healthy cells unharmed. Furthermore, cellular nanorobots can function as biosensors, detecting changes in cellular environments and providing valuable information for disease diagnosis and treatment monitoring²¹.

c) Hybrid nanorobots:

Hybrid nanorobot systems combine the strengths of both molecular and cellular nanorobots to create multifunctional and adaptable platforms for pharmaceutical applications. These nanorobot systems integrate the advantages of molecular nanorobots' precision and cellular nanorobots' biocompatibility. Hybrid nanorobots can be designed to carry multiple payloads, such as drugs, imaging agents, or therapeutic proteins, making them versatile tools for drug delivery and diagnostic applications. These systems may also incorporate various propulsion mechanisms, enabling them to navigate through different bodily fluids and tissues efficiently. The synergy between molecular and cellular components in hybrid nanorobots opens up new possibilities for tailored and personalized medicine, allowing for treatments that are specifically optimized for individual patients²²

Fabrication and Propulsion Techniques of Nanorobots:

Nanofabrication Methods:

Nanofabrication plays a crucial role in constructing nanorobots with precision and control. Various techniques are employed to fabricate nanoscale structures and components for nanorobot construction²⁰. Some commonly used nanofabrication methods include:

a) Top-Down Approach:

This method involves carving and shaping larger materials down to the desired nanoscale dimensions. Techniques like electron beam lithography and focused ion beam milling allow researchers to etch intricate patterns on a substrate, creating nanoscale features¹⁰.

b) Bottom-Up Approach:

In this approach, nanorobots are built from the ground up, starting with individual atoms or molecules. Self-assembly processes, where nanorobots spontaneously arrange themselves into the desired structures, are a prominent bottom-up approach. Additionally, techniques like DNA origami use DNA molecules as building blocks to create complex nanostructures¹¹.

Self-assembly and Nanomanipulation:

Self-assembly is a key concept in nanorobotics, allowing nanorobots to autonomously form complex structures or arrangements through non-covalent interactions. Researchers design the nanorobot components with complementary properties, enabling them to bind together spontaneously. Self-assembly simplifies the fabrication process and can lead to more scalable production of nanorobots. Nanomanipulation involves manipulating nanoscale objects using external control mechanisms. Techniques like atomic force microscopy (AFM) and optical tweezers enable scientists to move and position individual molecules or nanoparticles with precision. Nanomanipulation is essential for assembling intricate nanorobot components and achieving the desired functionality².

Various Propulsion Mechanisms for Nanorobots:

Propulsion is critical for nanorobots to navigate through complex biological environments and reach their intended targets. Several propulsion mechanisms have been explored for nanorobotics:

a) Chemical Propulsion: Nanorobots can be designed with catalytic components that react with their environment, generating propulsive forces. For example, nanorobots can use the surrounding biological fluids to produce gas bubbles that propel them forward²³.

b) Magnetic Propulsion: By incorporating magnetic nanoparticles into nanorobots, researchers can use external magnetic fields to guide and propel the nanorobots to specific locations within the body²⁴.

c) Acoustic Propulsion: Acoustic waves can be used to manipulate and move nanorobots. Ultrasound waves, for instance, can provide a non-invasive means of propelling nanorobots for targeted drug delivery³.

d) Flagellar Propulsion: Drawing inspiration from bacteria, nanorobots can be equipped with flagella-like appendages that mimic the bacterial swimming motion to move through fluids.

Each propulsion mechanism has its advantages and limitations, depending on the application and the environment in which the nanorobots operate. By combining propulsion mechanisms with sophisticated control systems, researchers aim to achieve precise and directed movement of nanorobots for optimal drug delivery and therapeutic outcomes¹⁴.The various propulsion mechanisms are shown in Table 2.

Navigation and Control of Nanorobots:

a) External Guidance and Control:

External guidance and control of nanorobots involve using external stimuli to direct and maneuver these tiny machines within the body. One common approach is the use of magnetic fields to guide magnetic nanorobots. By applying controlled magnetic fields from outside the body, researchers can precisely steer the movement of nanorobots to reach specific locations or targets. This approach offers a non-invasive and reversible method for guiding nanorobots, making it suitable for medical applications. Additionally, external control can be achieved using ultrasound, light, or other forms of energy that interact with nanorobots. For example, ultrasound waves can be employed to actuate nanorobots in a targeted manner, enabling them to move through tissues and fluids¹⁶.

b) Autonomous Navigation and Sensing:

Autonomous navigation and sensing are crucial features of nanorobots that allow them to function independently and intelligently. Nanorobots can be equipped with various sensors, such as pH sensors, temperature sensors, or specific biomarker detectors. These sensors enable nanorobots to gather real-time data about their environment and respond accordingly. For example, pH sensors can help nanorobots identify areas of high acidity, which might be indicative of cancerous tissues. Furthermore, nanorobots can be designed with sophisticated control systems that enable them to make decisions based on the sensory data they collect. Autonomous navigation allows nanorobots to adapt to changing conditions and choose the most efficient route to their targets. This level of autonomy is particularly valuable in situations where real-time adjustments are required during drug delivery or in response to biological changes¹⁷.

Challenges and Solutions in Nanorobot Control:

While nanorobot control holds great promise, it also comes with several challenges that need to be addressed for effective and safe operation:

a) Miniaturization and Complexity: As nanorobots shrink to the nanoscale, control becomes more challenging due to their reduced size and complexity. Developing control mechanisms that are compatible with nanorobot dimensions is a significant engineering hurdle²⁵.

b) Biocompatibility and Safety: Ensuring that external control methods and sensor systems do not cause harm or elicit adverse reactions in the body is a critical consideration. Nanorobots must be designed with biocompatible materials and controlled using safe energy sources¹⁹.

c) Real-time Feedback and Communication:

Establishing reliable communication between nanorobots and external devices is essential for real-time feedback and adjustments. Developing wireless communication methods that can penetrate biological tissues without interference is an ongoing research area¹.

d) Autonomy and Decision-making:

Creating robust and intelligent control systems that enable nanorobots to autonomously navigate through complex environments is a significant challenge. Nanorobots should be capable of making critical decisions while ensuring they do not cause harm to the patient¹.Innovative solutions such as swarm robotics, where multiple nanorobots work collaboratively, and bio-inspired control mechanisms, taking inspiration from natural systems, are being explored to address these challenges.

Interaction of Nanorobots with Biological Systems:

a) Biocompatibility and Safety Considerations:

Biocompatibility is a critical factor in determining the success of nanorobots in medical applications. Nanorobots must be engineered using materials that do not elicit toxic or harmful responses when interacting with biological systems. Biocompatible materials ensure that nanorobots can function effectively without causing adverse reactions in the body. Extensive biocompatibility testing is essential to evaluate the interactions between nanorobots and biological components, such as proteins, cells, and tissues. This testing helps identify potential risks and ensures the safe use of nanorobots in therapeutic interventions.To enhance biocompatibility, researchers use biodegradable materials for constructing nanorobots. Biodegradable nanorobots can degrade naturally in the body over time, reducing the risk of long-term accumulation and potential toxicity²⁶.

b) Nanorobot Interactions with Cells and Tissues:

Understanding how nanorobots interact with cells and tissues is crucial for effective drug delivery and other medical applications. Nanorobots must be designed to navigate through complex biological environments, such as blood vessels, tissues, and organs, without causing damage to cells or disrupting normal physiological functions.In drug delivery, nanorobots must interact selectively with target cells to deliver therapeutic payloads while avoiding healthy cells. Surface modifications and targeting ligands play a vital role in ensuring nanorobots specific interactions with diseased cells, enhancing their precision and therapeutic efficacy. Moreover, nanorobots can interact with cellular structures and organelles to deliver drugs or perform specific tasks within the cells. Understanding these interactions is essential for designing nanorobots with optimal functionality and safety²⁷.

c) Immunological Responses to Nanorobots:

The immune system plays a significant role in responding to foreign objects introduced into the body, including nanorobots. When nanorobots are administered into the bloodstream or tissues, they may trigger immune responses. The immune system can recognize nanorobots as foreign invaders, leading to the activation of immune cells and the production of antibodies. Researchers must carefully evaluate the immunological responses to nanorobots to ensure that these responses do not compromise the efficacy of nanorobot-based therapies or cause adverse effects. Strategies to mitigate immunological responses may include surface modifications to reduce immune recognition or the use of stealth coatings to evade immune surveillance. Additionally, nanorobot design should consider potential immune clearance mechanisms to extend their circulation time in the body and improve their effectiveness in drug delivery or other therapeutic applications²⁸.

Nanorobots for Site-Specific Drug Delivery:

Passive targeting and active targeting are two distinct approaches used by nanorobots for site-specific drug delivery.

a) Passive Targeting: Passive targeting takes advantage of the natural properties of nanorobots or drug carriers to accumulate preferentially at the site of interest. This is typically achieved through the enhanced permeability and retention (EPR) effect. In regions of inflammation or tumor growth, blood vessels are leakier, allowing nanorobots to extravasate and accumulate at the target site due to their small size. This phenomenon enables passive targeting of drugs to tumor tissues or inflamed areas, increasing drug concentration at the desired location while reducing exposure to healthy tissues²⁹.

b) Active Targeting: Active targeting involves the incorporation of specific targeting ligands or antibodies on the surface of nanorobots. These ligands can recognize and bind to specific receptors or biomarkers expressed on the surface of diseased cells. By actively homing in on these targets, nanorobots can achieve highly selective drug delivery, ensuring that therapeutic agents reach the desired cells with precision. Active targeting enhances the efficiency of drug delivery and reduces off-target effects, making it an attractive strategy for personalized medicine³⁰.

Smart Drug Delivery Using Nanorobots:

Smart drug delivery using nanorobots refers to the ability of these tiny machines to respond intelligently to environmental cues and deliver therapeutic agents in a controlled and targeted manner. By incorporating stimuli-responsive materials into nanorobot design, drug release can be triggered in response to specific conditions or signals present at the target site. For example, nanorobots can be engineered to respond to changes in pH, temperature, enzymatic activity, or other physiological parameters indicative of disease conditions. When exposed to such stimuli, the nanorobots release their cargo of drugs, ensuring precise drug delivery only at the site where it is needed. This on-demand drug release mechanism minimizes drug wastage, reduces systemic side effects, and enhances therapeutic efficacy²⁶.

Examples of Successful Site-Specific Drug Delivery:

Numerous examples demonstrate the effectiveness of nanorobots in achieving site-specific drug delivery:

Cancer Therapy: Nanorobots have been used for targeted drug delivery in cancer treatment. By actively targeting cancer cells with specific surface receptors, nanorobots can deliver chemotherapy drugs directly to the tumor site, increasing drug accumulation and minimizing damage to healthy tissues²⁷.

a) Neurological Disorders: In neurological disorders, such as Alzheimer's and Parkinson's diseases, nanorobots can cross the blood-brain barrier to deliver therapeutic agents directly to affected brain regions. This targeted approach holds promise for more effective treatments.

b) Inflammatory Diseases: Nanorobots can selectively target and deliver anti-inflammatory drugs to inflamed tissues, providing localized relief while avoiding systemic side effects.

c) Infection Control: Nanorobots can be designed to target and neutralize pathogens, such as bacteria or viruses, at the infection site, preventing their spread and reducing antibiotic resistance.

These examples highlight how nanorobots' ability to achieve site-specific drug delivery can revolutionize various medical treatments, enabling more efficient and precise therapeutic interventions.

Nanorobotics in Disease Treatment and Therapeutics:

a) Nanorobotics in Cancer Therapy:

Nanorobotics has shown immense potential in revolutionizing cancer therapy by offering innovative solutions for targeted drug delivery, early diagnosis, and precision treatment. In cancer therapy, nanorobots can be engineered to actively target tumor cells using specific surface receptors or biomarkers. By delivering chemotherapy drugs directly to the tumor site, nanorobots can increase drug concentration at the cancerous tissue while minimizing exposure to healthy cells, reducing side effects. Moreover, nanorobots can serve as carriers for various therapeutic agents, including gene therapies and immunotherapies, enhancing the overall effectiveness of cancer treatments. They can also be designed to respond to the tumor microenvironment, releasing drugs in response to factors such as low pH or enzyme activity specific to the tumor, further improving drug delivery precision. In addition to drug delivery, nanorobots can aid in cancer diagnostics through early detection of cancer biomarkers, enabling timely intervention and monitoring of treatment responses. The integration of nanorobotics in cancer therapy offers the potential for more personalized and effective treatments, improving patient outcomes and quality of life⁷.

b) Neurological Disorders and Nanorobot Interventions: Nanorobotics holds great promise in addressing the challenges of treating neurological disorders, which often involve complexities in drug delivery to the brain. The blood-brain barrier (BBB) acts as a formidable obstacle, preventing many therapeutic agents from reaching the brain. Nanorobots, with their small size and precise targeting capabilities, offer a potential solution for bypassing the BBB and delivering drugs to specific regions within the brain. By engineering nanorobots to recognize and penetrate the BBB or using focused ultrasound to assist in drug delivery, researchers have the opportunity to treat neurological conditions more effectively. Furthermore, nanorobots can be designed to target specific neural pathways and deliver neuroprotective agents or gene therapies directly to affected brain cells. This targeted intervention approach has the potential to slow down the progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's, and restore neural function.While the application of nanorobotics in neurological disorders is still in its early stages, it represents a promising avenue for advancing treatment options in this challenging field^4,24.

c) Infectious Diseases and Targeted Treatments: Nanorobotics offers unique opportunities in the field of infectious diseases by enabling targeted treatments against pathogens. Nanorobots can be engineered to detect and bind to specific bacteria or viruses, delivering antimicrobial agents or neutralizing toxins at the site of infection. This targeted approach allows for more effective and selective treatment, reducing the risk of developing drug resistance. In addition to direct pathogen targeting, nanorobots can support the immune system in fighting infections. By delivering immunomodulatory agents or enhancing immune responses, nanorobots can help the body combat infectious agents more effectively.Furthermore, nanorobots can be utilized in rapid diagnostics for infectious diseases, providing quick and accurate identification of pathogens, which is critical for timely treatment and containment of outbreaks¹².

Regulatory and Ethical Implications of Nanorobotics in Pharmaceuticals:

a) Current Regulatory Landscape for Nanorobotics:

The development and deployment of nanorobotics in pharmaceuticals raise important regulatory considerations. As nanorobotics is a rapidly evolving field, existing regulations may not be specifically tailored to address the unique characteristics and challenges posed by nanorobots. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are actively monitoring developments in nanorobotics and updating their guidelines to address safety, efficacy, and manufacturing concerns. Nanorobot-based drug delivery systems and medical devices must undergo rigorous testing and evaluation to ensure their safety and effectiveness before they can be approved for clinical use¹⁶.

b) Ethical Considerations in Nanorobotics Research:

As with any emerging technology, nanorobotics presents ethical considerations that require careful examination. Ethical concerns related to nanorobotics in pharmaceuticals include^14,15:

Informed Consent:

The use of nanorobots in medical treatments may require obtaining informed consent from patients. Patients must be adequately informed about the nature of the treatment, potential risks, and benefits associated with nanorobot-based interventions.

Autonomy and Privacy:

The use of nanorobots for medical interventions raises questions about patient autonomy and privacy. Patients should have the right to make informed decisions about their medical care and the use of nanorobotic technologies.

Equity and Access:

Ensuring equitable access to nanorobot-based treatments is essential. As with any new medical technology, concerns may arise about the availability and affordability of nanorobot-based pharmaceuticals, potentially creating disparities in healthcare access.

Unintended Consequences:

Nanorobotics research must also consider unintended consequences or potential unforeseen risks associated with nanorobot interventions. Long-term effects on the environment or unintended off-target effects on healthy cells could be important considerations.

c) Balancing Risks and Benefits in Clinical Applications:

The development and adoption of nanorobotics in pharmaceuticals require a careful balance between potential risks and benefits. Researchers and regulatory authorities must assess and manage potential risks associated with nanorobot interventions to ensure patient safety. This involves addressing concerns related to biocompatibility, immunological responses, long-term effects, and the potential for unintended interactions with biological systems. At the same time, the transformative potential of nanorobotics in pharmaceuticals should be recognized. Nanorobots offer the opportunity for precise drug delivery, enhanced therapeutic efficacy, and personalized medicine, which can significantly improve patient outcomes and quality of life. To strike a balance between risks and benefits, comprehensive preclinical studies and well-designed clinical trials are essential. Transparent communication about the technology's potential and limitations is vital for building public trust and fostering ethical decision-making.

Future Perspectives and Challenges:

Potential Future Developments in Nanorobotics:

The future of nanorobotics in pharmaceuticals holds immense promise for transforming healthcare. As research and technology continue to advance, several potential developments are anticipated:

a) Advanced Drug Delivery Systems:

Nanorobots are expected to become more sophisticated, with improved drug loading capacities and enhanced precision in drug delivery. This could lead to the development of novel therapies for a wide range of diseases, including cancer, neurodegenerative disorders, and infectious diseases³¹.

b) Targeted Therapies: The integration of nanorobots with advanced imaging techniques and personalized medicine approaches could lead to highly targeted therapies, tailored to individual patients' specific disease profiles^16,32.

c) Nanorobot Swarms: Researchers are exploring the concept of nanorobot swarms, where multiple nanorobots work collaboratively to achieve complex tasks. Such swarms could enhance drug delivery efficiency and enable the simultaneous targeting of multiple sites within the body²⁸.

d) Biohybrids and Bio-Inspired Nanorobots:

Biohybrids, combining biological components with synthetic nanorobots, could offer unique functionalities, leveraging the benefits of both natural and engineered systems. Additionally, researchers are drawing inspiration from biological systems to design nanorobots with improved mobility and adaptability²⁹.

e) Remote Sensing and Actuation:

Advancements in nanorobotics may enable remote sensing and actuation, allowing for external control of nanorobots using external energy sources, such as magnetic fields or light.

The future perspectives of nanorobots are shown in Figure 1.

Overcoming Current Challenges and Limitations:

To fully realize the potential of nanorobotics in pharmaceuticals, several challenges and limitations^18,30 need to be addressed:

a) Biocompatibility and Safety: Ensuring the biocompatibility and long-term safety of nanorobots is crucial for their clinical translation. Comprehensive preclinical studies and safety assessments are necessary to mitigate potential risks.

b) Regulatory Hurdles: The development and approval of nanorobotic-based pharmaceuticals require navigating complex regulatory processes. Collaborative efforts between researchers, regulatory agencies, and industry stakeholders are essential to streamline approval pathways.

c) Manufacturing Scalability: Mass production and scalable manufacturing of nanorobots at a reasonable cost are essential to facilitate widespread clinical adoption.

d) Immunological Responses: Understanding and managing immunological responses to nanorobots are critical to prevent immune clearance and adverse reactions.

e) Real-time Control and Navigation: Developing sophisticated control systems that allow real-time navigation and adjustment of nanorobots within the body remains a challenge.

f) Integrating Nanorobotics into Mainstream Pharmaceutical Practices: The successful integration of nanorobotics into mainstream pharmaceutical practices requires interdisciplinary collaboration and a translational approach:

Collaboration among Researchers:

Nanorobotics researchers, material scientists, biologists, clinicians, and regulatory experts must collaborate to address the multifaceted challenges in nanorobot development and clinical implementation.

Investment and Funding:

Continued investment in nanorobotics research and development is necessary to advance the field and accelerate its translation into clinical applications.

Clinical Trials and Validation:

Rigorous clinical trials are essential to validate the safety and efficacy of nanorobot-based pharmaceuticals. Demonstrating clinical effectiveness is crucial for gaining regulatory approval and widespread acceptance.

Education and Public Awareness:

Educating healthcare professionals, patients, and the general public about the potential benefits and safety considerations of nanorobotics is vital for fostering acceptance and ethical usage.

CONCLUSION:

In conclusion, nanorobotics in pharmaceuticals offers a new era of medical possibilities. By harnessing the potential of nanorobots, we can create a future where drug delivery is precise, treatments are targeted, and patient outcomes are significantly improved. The implications of nanorobotics in pharmaceuticals are vast, offering the potential to transform the landscape of medicine and improve the lives of countless patients worldwide. As research progresses and technology advances, nanorobotics holds the promise of revolutionizing drug delivery and development, ushering in a new era of personalized and effective medical interventions.

CONFLICT OF INTEREST:

The authors declare no conflicts of interest.

ACKNOWLEDGMENTS:

The authors would like to thank Ms. M. Vinny Therissa, Assistant Professor, Aditya College of Pharmacy for herkind support during the preparation of this work.

REFERENCES:

1. Hey A. Feynman and Computation. CRC Press; 2018.

2. Homberger M, Simon U. On the application potential of gold nanoparticles in nanoelectronics and biomedicine. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 2010; 368(1915): 1405-53. doi: 10.1098/rsta.2009.0275

3. Baswaraj D, Vasanthi MZ, Deepthi S. Effect of Nanotechnology. International Journal of Computer Technology and Applications 2012; 3(4).

4. Upadhyay RK. Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier. Biomed Res Int 2014; 2014: 869269. doi: 10.1155/2014/869269

5. Patil LB, Patil SS, Nitalikar MM, Magdum CS, Mohite SK. A Review on-Novel Approaches in Nanorobotics. Asian Jour Pharmac Rese 2016; 6(4): 217. doi: 10.5958/2231-5691.2016.00030.7

6. S. Patel S, N. Patel P. A Brief Review on Nanorobotics Applications in Medicine and Future Prospects. AJPS Published online March 21, 2023: 19-28. doi: 10.52711/2231-5659.2023.00004

7. Abrar M, Sheikh T, Mohammed S, Ahmad FM, Shaikh U. Nanorobotics in Cancer Treatment: A Review. Rese Jour Pharmaceut Dosag Form and Technol 2019; 11(1): 43. doi: 10.5958/0975-4377.2019.00007.7

8. Kumar R, Jha AK, Jain SK. Nanomedicine: An Emerging Area of Nanotechnology. Research Journal of Pharmaceutical Dosage Forms and Technology 2009; 1(1): 18-21.

9. Narasimha L, Selvan A, Jairam D, Suthakaran R. Artificial red blood cells using nanotechnology. Research Journal of Pharmacy and Technology 2014; 7(11): 1323-9.

10. Sriram K, Vishnupriya V, Gayathri R. Review on the role of Nanotechnology in Dentistry and Medicine. Rese Jour of Pharm and Technol 2016; 9(8): 1249. doi: 10.5958/0974-360X.2016.00236.5

11. Saleh NA, Wahid TAA. Nanotechnology with X-rays plays an essential role in improving radiation therapy for malignant breast cells. Rese Jour of Pharm and Technol 2017; 10(12): 4129. doi: 10.5958/0974-360X.2017.00751.X

12. Krishnan PRR, Sivakumar R. Nanotechnology: Modern Formulation and Evaluation Techniques -An Overview. Rese Jour of Pharm and Technol 2019; 12(8): 4039. doi: 10.5958/0974-360X.2019.00696.6

13. Thiruchelvi R, Sikdar E, Das A, Rajakumari K. Nanobots in Today’s World. Rese Jour of Pharm and Technol. 2020; 13(4): 2033. doi: 10.5958/0974-360X.2020.00366.2

14. Chandran A, Ammu, Merlin NJ, Dharan SS. Applications of Robotics in Urology-A Review. Asia Journ of Resear in Pharmac Scie. 2019; 9(1): 6. doi: 10.5958/2231-5659.2019.00002.X

15. Fernandes P, Christina RC. Robotic nursing: Life saver in pandemic. Asian Journal of Nursing Education and Research. 2021; 11(2): 282-4.

16. Tibbals HF. Medical Nanotechnology and Nanomedicine. Crc Press; 2017.

17. Suganya K, Rethinavel Subramanian A. A survey on Nanotechnology and Its Medical Applications.

18. Soto F, Chrostowski R. Frontiers of medical micro/nanorobotics: in vivo applications and commercialization perspectives toward clinical uses. Frontiers in Bioengineering and Biotechnology 2018; 6: 170. doi: 10.3389/fbioe.2018.00170

19. Singh AV, Ansari MHD, Laux P, Luch A. Micro-nanorobots: important considerations when developing novel drug delivery platforms. Expert Opinion on Drug Delivery. 2019; 16(11): 1259-75. doi: 10.1080/17425247.2019.1676228

20. Ratner MA, Ratner D. Nanotechnology: A Gentle Introduction to the next Big Idea. Prentice Hall Professional; 2003.

21. Kumar A, Tan A, Wong J, Spagnoli JC, Lam J, Blevins BD, et al. Nanotechnology for neuroscience: promising approaches for diagnostics, therapeutics and brain activity mapping. Advanced Functional Materials. 2017; 27(39): 1700489. doi: 10.1002/adfm.201700489

22. Jahanban-Esfahlan A, Seidi K, Jaymand M, Schmidt TL, Majdi H, Javaheri T, et al. Dynamic DNA nanostructures in biomedicine: Beauty, utility and limits. Journal of Controlled Release. 2019; 315: 166-85. doi: 10.1016/j.jconrel.2019.10.003

23. Contera S. Nano Comes to Life: How Nanotechnology Is Transforming Medicine and the Future of Biology. Princeton University Press; 2019.

24. Freitas RA. Current status of nanomedicine and medical nanorobotics. Journal of Computational and Theoretical Nanoscience 2005; 2(1): 1-25.

25. Soto C, Recoba R, Barron H, Alvarez C, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology.Published online November 1, 2003.

26. Wang D, Mukhtar A, Humayun M, Wu K, Du Z, Wang S, et al. A Critical Review on Nanowire-Motors: Design, Mechanism and Applications. The Chemical Record. 2022; 22(8): e202200016. doi: 10.1002/tcr.202200016

27. Mathur D, Medintz IL. The growing development of DNA nanostructures for potential healthcare-related applications. Advanced Healthcare Materials. 2019;8(9):1801546.

28. Li J, Pumera M. 3D printing of functional microrobots. Chemical Society Reviews 2021; 50(4): 2794-838. doi: 10.1039/D0CS01062F

29. Keiper A. The Nanotechnology Revolution. The New Atlantis. 2003; 2: 17-34.

30. Chowdhury R. A review on the application of nanotechnology in Pharmaceutical Science. Published online 2015.

31. Davies DJ, Vaccaro AR, Morris SM, Herzer N, Schenning AP, Bastiaansen CW. A printable optical time-temperature integrator based on shape memory in a chiral nematic polymer network. Advanced Functional Materials. 2013; 23(21): 2723-7.

32. Ahmad W, Khan T, Basit I, Imran J. A Comprehensive Review on Targeted Drug Delivery System. AJPR Published online November 22, 2022:335-40. doi: 10.52711/2231-5691.2022.00053

Received on 07.08.2023 Modified on 20.09.2023

Res. J. Pharma. Dosage Forms and Tech.2024; 16(1):81-90.

DOI: 10.52711/0975-4377.2024.00014